Sustainability & Climate

Synthpop becomes the first healthcare AI partner in Google's Gemini Enterprise, signaling a major shift from AI experiments to operational reality for providers.

Celebrating 50 years, the world's top locker maker rebrands to lead the charge in performance-driven design and neuro-inclusive workspaces.

A landmark $6M verdict against Meta and YouTube has intensified the debate on social media's role in youth stress, pushing alternative philosophies into the spotlight.

Germain Hotels opens its 20th property, the Alt Hotel Ottawa Airport, offering a direct walkway to the terminal and blending local flair with traveler convenience.

Striking Metro workers accuse a major distributor of strikebreaking, sparking fears of wider fruit and vegetable shortages across Quebec grocery stores.

With a $4.6M seed round, Cloneable's new agentic AI platform captures the invaluable knowledge of retiring infrastructure experts to prevent a looming brain drain.

A new non-viral gene therapy targeting iron buildup in the eye has completed its Phase I trial, offering a potential new path for millions with dry AMD.

A novel RNA vaccine targeting hidden cancer antigens gets UK approval for a clinical trial, offering new hope for patients with hard-to-treat ovarian cancer.

Canadian giant Apotex acquires Cumberland's U.S. branded drugs for $100M, a move that expands its hospital presence and pivots Cumberland to a biotech.

With FDA clearance, Neuvotion's NeuStim™ platform uses AI and non-invasive stimulation to offer new hope for hand movement after a stroke or spinal injury.

Backed by military funding, a novel protein therapy that actively grows bone has finished a key clinical trial, promising to revolutionize dental surgery.

A Texas program teaches students with disabilities to recycle tech, creating job skills, confidence, and a self-sustaining model for schools.

Strider Education Foundation launches two new programs, offering a blueprint for inclusion and empowering individuals with disabilities through the joy of cycling.

A new T-cell therapy, RPTR-1-201, enters clinical trials, offering hope for hard-to-treat solid tumors by targeting a shared, multi-cancer marker.

After a year of massive write-downs, the consumer goods giant charts a new course focused on growth, debt reduction, and operational resilience.

A historically warm winter with record low snowfall sends Vail Resorts' revenue and visitation tumbling, raising alarms for the entire ski industry.

RIMAN rallies 2,000 in Macau, unveiling a $3M bio-material and a bold strategy to dominate the competitive APAC K-beauty direct selling market.

Nearly 30,000 students raised funds to plant a mangrove forest, redefining education and protecting the endangered Bengal tiger's vital habitat.

Millions of Britons lose a night's sleep weekly, with the sickest suffering most. As traditional remedies fail, many are now exploring medical cannabis.

A new coated thin glass from NxLite promises to deliver triple-pane window efficiency in a double-pane package, removing major barriers for manufacturers.